サマリー

The complement system is a part of the immune system that enhances, or complements, the ability of antibodies to clear small organisms or damaged cells from an organism, promote inflammation and attack the pathogen’s cell membrane. While the complement system is essential to maintaining health, it can also become over-activated, contributing to the development of numerous devastating diseases.

Market Analysis and Insights: Global Complement Targeted Therapeutics Market
In 2020, the global Complement Targeted Therapeutics market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027.

Global Complement Targeted Therapeutics Scope and Market Size
Complement Targeted Therapeutics market is segmented by companies, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Complement Targeted Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on market size and forecast for the period 2016-2027.
Segment by Type, the Complement Targeted Therapeutics market is segmented into Paroxysmal Nocturnal Haemoglobinuria, Atypical Haemolytic Uraemic Syndrome (AHUS), etc.
Segment by Application, the Complement Targeted Therapeutics market is segmented into Hospital Pharmacies, Retail Pharamacies, Online Pharmacies, etc.

Regional and Country-level Analysis
The report offers exhaustive assessment of different region-wise and country-wise Complement Targeted Therapeutics markets such as the U.S., Canada, Germany, France, the U.K., Italy, Russia, China, Japan, South Korea, Taiwan, India, Australia, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Argentina, Saudi Arabia, UAE, Turkey, etc.
The report includes country-wise and region-wise market size for the period 2016-2027, by countries (regions), by Type, and by Application, as well as by players for North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Competitive Landscape and Complement Targeted Therapeutics Market Share Analysis
Complement Targeted Therapeutics market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2016-2021. Details included are company description, major business, company total revenue and revenue generated in Complement Targeted Therapeutics business, the date to enter into the Complement Targeted Therapeutics market, Complement Targeted Therapeutics product introduction, recent developments, etc.
The major vendors include Creative Biolabs, Novartis AG, Alexion Pharmaceuticals, Merck, Pfizer, Allergan, AbbVie, etc.

ページTOPに戻る

目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Complement Targeted Therapeutics Market Size by Type: 2016 VS 2021 VS 2027
1.2.2 Paroxysmal Nocturnal Haemoglobinuria
1.2.3 Atypical Haemolytic Uraemic Syndrome (AHUS)
1.3 Market by Application
1.3.1 Global Complement Targeted Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharamacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trend
2.1 Global Complement Targeted Therapeutics Market Perspective (2016-2027)
2.2 Global Complement Targeted Therapeutics Growth Trends by Regions
2.2.1 Complement Targeted Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Complement Targeted Therapeutics Historic Market Size by Regions (2016-2021)
2.2.3 Complement Targeted Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Industry Trends and Growth Strategy
2.3.1 Complement Targeted Therapeutics Industry Trends
2.3.2 Complement Targeted Therapeutics Market Drivers
2.3.3 Complement Targeted Therapeutics Market Challenges
2.3.4 Complement Targeted Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Complement Targeted Therapeutics Players by Market Size
3.1.1 Players Covered: Ranking by Complement Targeted Therapeutics Revenue
3.1.2 Global Top Complement Targeted Therapeutics Players by Revenue (2016-2021)
3.1.3 Global Complement Targeted Therapeutics Revenue Market Share by Players (2016-2021)
3.1.4 Global Complement Targeted Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Complement Targeted Therapeutics Market Concentration Ratio
3.2.1 Global Complement Targeted Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 5 and Top 10 Players by Complement Targeted Therapeutics Revenue in 2020
3.3 Complement Targeted Therapeutics Key Players Head office and Area Served
3.4 Key Players Complement Targeted Therapeutics Product Solution and Service
3.5 Date of Enter into Complement Targeted Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Global Complement Targeted Therapeutics Breakdown Data by Type (2016-2027)
4.1 Global Complement Targeted Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Complement Targeted Therapeutics Forecasted Market Size by Type (2022-2027)

5 Global Complement Targeted Therapeutics Breakdown Data by Application (2016-2027)
5.1 Global Complement Targeted Therapeutics Historic Market Size by Application (2016-2021)
5.2 Complement Targeted Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Complement Targeted Therapeutics Market Size (2016-2027)
6.2 Key Complement Targeted Therapeutics Players Market Share in North America (2020-2021)
6.3 North America Complement Targeted Therapeutics Market Size by Country
6.3.1 North America Complement Targeted Therapeutics Market Size by Country (2016-2021)
6.3.2 North America Complement Targeted Therapeutics Market Size Forecast by Country (2022-2027)
6.4 U.S. Market Size Analysis
6.4.1 U.S. Complement Targeted Therapeutics Market Size (2016-2027)
6.4.2 U.S. Complement Targeted Therapeutics Market Size by Type (2016-2027)
6.4.3 U.S. Complement Targeted Therapeutics Market Size by Application (2016-2027)
6.5 Canada Market Size Analysis
6.5.1 Canada Complement Targeted Therapeutics Market Size (2016-2027)
6.5.2 Canada Complement Targeted Therapeutics Market Size by Type (2016-2027)
6.5.3 Canada Complement Targeted Therapeutics Market Size by Application (2016-2027)

7 Europe
7.1 Europe Complement Targeted Therapeutics Market Size (2016-2027)
7.2 Key Complement Targeted Therapeutics Players Market Share in Europe (2020-2021)
7.3 Europe Complement Targeted Therapeutics Market Size by Country
7.3.1 Europe Complement Targeted Therapeutics Market Size by Country (2016-2021)
7.3.2 Europe Complement Targeted Therapeutics Market Size Forecast by Country (2022-2027)
7.4 Germany Market Size Analysis
7.4.1 Germany Complement Targeted Therapeutics Market Size (2016-2027)
7.4.2 Germany Complement Targeted Therapeutics Market Size by Type (2016-2027)
7.4.3 Germany Complement Targeted Therapeutics Market Size by Application (2016-2027)
7.5 France Market Size Analysis
7.5.1 France Complement Targeted Therapeutics Market Size (2016-2027)
7.5.2 France Complement Targeted Therapeutics Market Size by Type (2016-2027)
7.5.3 France Complement Targeted Therapeutics Market Size by Application (2016-2027)
7.6 U.K. Market Size Analysis
7.6.1 U.K. Complement Targeted Therapeutics Market Size (2016-2027)
7.6.2 U.K. Complement Targeted Therapeutics Market Size by Type (2016-2027)
7.6.3 U.K. Complement Targeted Therapeutics Market Size by Application (2016-2027)
7.7 Italy Market Size Analysis
7.7.1 Italy Complement Targeted Therapeutics Market Size (2016-2027)
7.7.2 Italy Complement Targeted Therapeutics Market Size by Type (2016-2027)
7.7.3 Italy Complement Targeted Therapeutics Market Size by Application (2016-2027)
7.8 Russia Market Size Analysis
7.8.1 Russia Complement Targeted Therapeutics Market Size (2016-2027)
7.8.2 Russia Complement Targeted Therapeutics Market Size by Type (2016-2027)
7.8.3 Russia Complement Targeted Therapeutics Market Size by Application (2016-2027)

8 Asia-Pacific
8.1 Asia-Pacific Complement Targeted Therapeutics Market Size (2016-2027)
8.2 Key Complement Targeted Therapeutics Players Market Share in Asia-Pacific (2020-2021)
8.3 Asia-Pacific Complement Targeted Therapeutics Market Size by Region
8.3.1 Asia-Pacific Complement Targeted Therapeutics Market Size by Region (2016-2021)
8.3.2 Asia-Pacific Complement Targeted Therapeutics Market Size Forecast by Region (2022-2027)
8.4 China Market Size Analysis
8.4.1 China Complement Targeted Therapeutics Market Size (2016-2027)
8.4.2 China Complement Targeted Therapeutics Market Size by Type (2016-2027)
8.4.3 China Complement Targeted Therapeutics Market Size by Application (2016-2027)
8.5 Japan Market Size Analysis
8.5.1 Japan Complement Targeted Therapeutics Market Size (2016-2027)
8.5.2 Japan Complement Targeted Therapeutics Market Size by Type (2016-2027)
8.5.3 Japan Complement Targeted Therapeutics Market Size by Application (2016-2027)
8.6 South Korea Market Size Analysis
8.6.1 South Korea Complement Targeted Therapeutics Market Size (2016-2027)
8.6.2 South Korea Complement Targeted Therapeutics Market Size by Type (2016-2027)
8.6.3 South Korea Complement Targeted Therapeutics Market Size by Application (2016-2027)
8.7 India Market Size Analysis
8.7.1 India Complement Targeted Therapeutics Market Size (2016-2027)
8.7.2 India Complement Targeted Therapeutics Market Size by Type (2016-2027)
8.7.3 India Complement Targeted Therapeutics Market Size by Application (2016-2027)
8.8 Australia Market Size Analysis
8.8.1 Australia Complement Targeted Therapeutics Market Size (2016-2027)
8.8.2 Australia Complement Targeted Therapeutics Market Size by Type (2016-2027)
8.8.3 Australia Complement Targeted Therapeutics Market Size by Application (2016-2027)
8.9 Taiwan Market Size Analysis
8.9.1 Taiwan Complement Targeted Therapeutics Market Size (2016-2027)
8.9.2 Taiwan Complement Targeted Therapeutics Market Size by Type (2016-2027)
8.9.3 Taiwan Complement Targeted Therapeutics Market Size by Application (2016-2027)
8.10 Indonesia Market Size Analysis
8.10.1 Indonesia Complement Targeted Therapeutics Market Size (2016-2027)
8.10.2 Indonesia Complement Targeted Therapeutics Market Size by Type (2016-2027)
8.10.3 Indonesia Complement Targeted Therapeutics Market Size by Application (2016-2027)
8.11 Thailand Market Size Analysis
8.11.1 Thailand Complement Targeted Therapeutics Market Size (2016-2027)
8.11.2 Thailand Complement Targeted Therapeutics Market Size by Type (2016-2027)
8.11.3 Thailand Complement Targeted Therapeutics Market Size by Application (2016-2027)
8.12 Malaysia Market Size Analysis
8.12.1 Malaysia Complement Targeted Therapeutics Market Size (2016-2027)
8.12.2 Malaysia Complement Targeted Therapeutics Market Size by Type (2016-2027)
8.12.3 Malaysia Complement Targeted Therapeutics Market Size by Application (2016-2027)
8.13 Philippines Market Size Analysis
8.13.1 Philippines Complement Targeted Therapeutics Market Size (2016-2027)
8.13.2 Philippines Complement Targeted Therapeutics Market Size by Type (2016-2027)
8.13.3 Philippines Complement Targeted Therapeutics Market Size by Application (2016-2027)
8.14 Vietnam Market Size Analysis
8.14.1 Vietnam Complement Targeted Therapeutics Market Size (2016-2027)
8.14.2 Vietnam Complement Targeted Therapeutics Market Size by Type (2016-2027)
8.14.3 Vietnam Complement Targeted Therapeutics Market Size by Application (2016-2027)

9 Latin America
9.1 Latin America Complement Targeted Therapeutics Market Size (2016-2027)
9.2 Key Complement Targeted Therapeutics Players Market Share in Latin America (2020-2021)
9.3 Latin America Complement Targeted Therapeutics Market Size by Country
9.3.1 Latin America Complement Targeted Therapeutics Market Size by Country (2016-2021)
9.3.2 Latin America Complement Targeted Therapeutics Market Size Forecast by Country (2022-2027)
9.4 Mexico Market Size Analysis
9.4.1 Mexico Complement Targeted Therapeutics Market Size (2016-2027)
9.4.2 Mexico Complement Targeted Therapeutics Market Size by Type (2016-2027)
9.4.3 Mexico Complement Targeted Therapeutics Market Size by Application (2016-2027)
9.5 Brazil Market Size Analysis
9.5.1 Brazil Complement Targeted Therapeutics Market Size (2016-2027)
9.5.2 Brazil Complement Targeted Therapeutics Market Size by Type (2016-2027)
9.5.3 Brazil Complement Targeted Therapeutics Market Size by Application (2016-2027)
9.6 Argentina Market Size Analysis
9.6.1 Argentina Complement Targeted Therapeutics Market Size (2016-2027)
9.6.2 Argentina Complement Targeted Therapeutics Market Size by Type (2016-2027)
9.6.3 Argentina Complement Targeted Therapeutics Market Size by Application (2016-2027)

10 Middle East & Africa
10.1 Middle East & Africa Complement Targeted Therapeutics Market Size (2016-2027)
10.2 Key Complement Targeted Therapeutics Players Market Share in Middle East & Africa (2020-2021)
10.3 Middle East & Africa Complement Targeted Therapeutics Market Size by Country
10.3.1 Middle East & Africa Complement Targeted Therapeutics Market Size by Country (2016-2021)
10.3.2 Middle East & Africa Complement Targeted Therapeutics Market Size Forecast by Country (2022-2027)
10.4 Turkey Market Size Analysis
10.4.1 Turkey Complement Targeted Therapeutics Market Size (2016-2027)
10.4.2 Turkey Complement Targeted Therapeutics Market Size by Type (2016-2027)
10.4.3 Turkey Complement Targeted Therapeutics Market Size by Application (2016-2027)
10.5 Saudi Arabia Market Size Analysis
10.5.1 Saudi Arabia Complement Targeted Therapeutics Market Size (2016-2027)
10.5.2 Saudi Arabia Complement Targeted Therapeutics Market Size by Type (2016-2027)
10.5.3 Saudi Arabia Complement Targeted Therapeutics Market Size by Application (2016-2027)
10.6 U.A.E Market Size Analysis
10.6.1 U.A.E Complement Targeted Therapeutics Market Size (2016-2027)
10.6.2 U.A.E Complement Targeted Therapeutics Market Size by Type (2016-2027)
10.6.3 U.A.E Complement Targeted Therapeutics Market Size by Application (2016-2027)

11 Key Players Profiles
11.1 Creative Biolabs
11.1.1 Creative Biolabs Company Details
11.1.2 Creative Biolabs Business Overview and Its Total Revenue
11.1.3 Creative Biolabs Complement Targeted Therapeutics Introduction
11.1.4 Creative Biolabs Revenue in Complement Targeted Therapeutics Business (2016-2021)
11.1.5 Creative Biolabs Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Company Details
11.2.2 Novartis AG Business Overview and Its Total Revenue
11.2.3 Novartis AG Complement Targeted Therapeutics Introduction
11.2.4 Novartis AG Revenue in Complement Targeted Therapeutics Business (2016-2021)
11.2.5 Novartis AG Recent Development
11.3 Alexion Pharmaceuticals
11.3.1 Alexion Pharmaceuticals Company Details
11.3.2 Alexion Pharmaceuticals Business Overview and Its Total Revenue
11.3.3 Alexion Pharmaceuticals Complement Targeted Therapeutics Introduction
11.3.4 Alexion Pharmaceuticals Revenue in Complement Targeted Therapeutics Business (2016-2021)
11.3.5 Alexion Pharmaceuticals Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview and Its Total Revenue
11.4.3 Merck Complement Targeted Therapeutics Introduction
11.4.4 Merck Revenue in Complement Targeted Therapeutics Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview and Its Total Revenue
11.5.3 Pfizer Complement Targeted Therapeutics Introduction
11.5.4 Pfizer Revenue in Complement Targeted Therapeutics Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 Allergan
11.6.1 Allergan Company Details
11.6.2 Allergan Business Overview and Its Total Revenue
11.6.3 Allergan Complement Targeted Therapeutics Introduction
11.6.4 Allergan Revenue in Complement Targeted Therapeutics Business (2016-2021)
11.6.5 Allergan Recent Development
11.7 AbbVie
11.7.1 AbbVie Company Details
11.7.2 AbbVie Business Overview and Its Total Revenue
11.7.3 AbbVie Complement Targeted Therapeutics Introduction
11.7.4 AbbVie Revenue in Complement Targeted Therapeutics Business (2016-2021)
11.7.5 AbbVie Recent Development

12 Analyst's Viewpoints/Conclusion

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details